Company Encyclopedia
View More
name
Bio-Rad Lab-B
BIO.B.US
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications.
770.89 B
BIO.B.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking26/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-9.50%D
    • Profit Margin-26.43%E
    • Gross Margin52.50%B
  • Growth ScoreD
    • Revenue YoY-0.88%D
    • Net Profit YoY13.20%C
    • Total Assets YoY-8.55%E
    • Net Assets YoY-10.03%D
  • Cash ScoreD
    • Cash Flow Margin-378.38%D
    • OCF YoY-0.88%D
  • Operating ScoreD
    • Turnover0.25D
  • Debt ScoreB
    • Gearing Ratio30.52%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above Fifty Day Moving Average - Here's Why

    Bio-Rad Laboratories' stock price crossed above its 50-day moving average, trading as high as $310.70. The stock has a market cap of $8.38 billion and a PE ratio of -12.78. Despite a Hold rating from analysts, Bio-Rad Laboratories wasn't among the top five stocks recommended by analysts. The company reported $2.26 EPS for the last quarter with revenue of $653 million.

    Market Beat·
    US
    BIO.B
    0.00%
    Market Beat·
    US
    BIO.B
    0.00%

    Bio-Rad Lab-B | 10-Q: FY2025 Q3 Revenue: USD 653 M

    LB filings·
    US
    BIO.B
    0.00%
    LB filings·
    US
    BIO.B
    0.00%

    Bio-Rad Lab-B | 8-K: FY2025 Q3 Revenue: USD 653 M

    LB filings·
    US
    BIO.B
    0.00%
    LB filings·
    US
    BIO.B
    0.00%

    Bio-Rad Lab-B | 10-Q: FY2025 Q2 Revenue: USD 651.6 M

    LB filings·
    US
    BIO.B
    0.00%
    LB filings·
    US
    BIO.B
    0.00%

    Bio-Rad Lab-B | 8-K: FY2025 Q2 Revenue: USD 651.6 M

    LB filings·
    US
    BIO.B
    0.00%
    LB filings·
    US
    BIO.B
    0.00%
    Posts
    View More

    News verification $XTALPI(02228.HK) The news you mentioned is basically accurate. I have cross-verified it through multiple reliable sources (such as the company's official press releases, Yahoo Finan......

    © 2025 Longbridge｜Disclaimer